Pre-vaccination and early B cell signatures predict antibody response to SARS-CoV-2 mRNA vaccine

Autor: Trihemasava K, Sandeep Narpala, Strich, Anthony S. Fauci, Adrian B. McDermott, Wang Y, William W. Lau, Richard W. Childs, Rachmaninoff N, Li Y, Daniel S. Chertow, Michael C. Sneller, de Assis Fl, Richard T. Davey, Clarisa M. Buckner, Catherine Seamon, Lela Kardava, Sarah O’Connell, Susan Moir, Tae-Wook Chun, Anthony F. Suffredini, Robert Reger, John S. Tsang, Xiaoling Zhang, Chiang C, Wei Wang, McCormack Ge

Publikováno v: medRxiv
article-version (status) pre
article-version (number) 1

Messenger RNA (mRNA) vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are highly effective at inducing protective immunity. However, weak antibody responses are seen in some individuals, and cellular correlates of immunit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c0b4b97a3c082b771fbd4424ba75268
http://europepmc.org/articles/PMC8282109

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Pre-vaccination and early B cell signatures predict antibody response to SARS-CoV-2 mRNA vaccine.

Autor: Kardava L; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA., Rachmaninoff N; Multiscale Systems Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USA., Lau WW; Multiscale Systems Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USA., Buckner CM; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA., Trihemasava K; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA., de Assis FL; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA., Wang W; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA., Zhang X; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA., Wang Y; Institute for Bioscience and Biotechnology Research, Rockville, MD, USA., Chiang CI; Institute for Bioscience and Biotechnology Research, Rockville, MD, USA., Narpala S; Vaccine Research Center, NIAID, NIH, Bethesda, MD, USA., Reger R; Cellular and Molecular Therapeutics Branch, National Heart, Lung and Blood Institute, NIH, Bethesda, MD, USA., McCormack GE; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA., Seamon CA; Critical Care Medicine Department, National Institutes of Health Clinical Center, NIH, Bethesda, MD, USA., Childs RW; Cellular and Molecular Therapeutics Branch, National Heart, Lung and Blood Institute, NIH, Bethesda, MD, USA.; United States Public Health Service Commissioned Corps, Rockville, MD, USA., Suffredini AF; Critical Care Medicine Department, National Institutes of Health Clinical Center, NIH, Bethesda, MD, USA., Strich JR; Critical Care Medicine Department, National Institutes of Health Clinical Center, NIH, Bethesda, MD, USA.; United States Public Health Service Commissioned Corps, Rockville, MD, USA., Chertow DS; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.; Critical Care Medicine Department, National Institutes of Health Clinical Center, NIH, Bethesda, MD, USA.; United States Public Health Service Commissioned Corps, Rockville, MD, USA., Davey RT; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA., Sneller MC; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA., O'Connell S; Vaccine Research Center, NIAID, NIH, Bethesda, MD, USA., Li Y; Institute for Bioscience and Biotechnology Research, Rockville, MD, USA.; Department of Microbiology and Immunology and Center for Biomolecular Therapeutics, University of Maryland School of Medicine, Baltimore, MD, USA., McDermott A; Vaccine Research Center, NIAID, NIH, Bethesda, MD, USA., Chun TW; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA., Fauci AS; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA., Tsang JS; Multiscale Systems Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, USA.; NIH Center for Human Immunology, NIAID, NIH, Bethesda, MD, USA., Moir S; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.

Publikováno v: MedRxiv : the preprint server for health sciences [medRxiv] 2021 Jul 07. Date of Electronic Publication: 2021 Jul 07.